Literature DB >> 33147612

CDR132L: another brick in the wall towards the use of miRNAs to treat cardiovascular disease.

Yvan Devaux1, Lina Badimon2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33147612     DOI: 10.1093/eurheartj/ehaa870

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

1.  The year in cardiovascular medicine 2021: heart failure and cardiomyopathies.

Authors:  Johann Bauersachs; Rudolf A de Boer; JoAnn Lindenfeld; Biykem Bozkurt
Journal:  Eur Heart J       Date:  2022-02-03       Impact factor: 35.855

2.  PDGF-BB promotes vascular smooth muscle cell migration by enhancing Pim-1 expression via inhibiting miR-214.

Authors:  Jinshan Zhou; Lifang Shao; Jianghao Yu; Junchao Huang; Qiang Feng
Journal:  Ann Transl Med       Date:  2021-12

Review 3.  miR-484: A Potential Biomarker in Health and Disease.

Authors:  Yin-Zhao Jia; Jing Liu; Geng-Qiao Wang; Zi-Fang Song
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.